Abeona Therapeutics Inc. Common Stock

ABEONASDAQ • USD
2.45 USD
↘ 0.28 (10.30%)AT CLOSE (03:59 PM EST)
2.47
↗ 0.02 (0.82%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
2.47
↗ 0.02 (0.82%)
🔴Market: CLOSED

ABEO is currently priced at $2.44. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ABEO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 19, 2026.

Open?$2.70
High?$2.76
Low?$2.42
Prev. Close?$2.73
Volume?1.9M
Avg. Volume?2.0M
VWAP?$2.53
Rel. Volume?0.98x
Bid / Ask
Bid?$2.45 × 800
Ask?$2.73 × 200
Spread?$0.28
Midpoint?$2.59
Valuation & Ratios
Market Cap?151.0M
Shares Out?57.1M
Float?47.5M
Float %?83.1%
P/E Ratio?N/A
P/B Ratio?1.20
EPS?-$1.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Employees
226
Market Cap
168.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1980-09-19
Address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
Phone: 646-813-4701
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
60
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.68Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?35.53%Squeeze Risk
Short Interest?16.9M
Days to Cover?21.7
Free Float47.5M
Avg Daily Volume778.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.69Strong
Quick Ratio?5.52Strong
Cash Ratio?2.39Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
93
1.20CHEAP▾
P/S?
Peers
100
S&P
39
3.87FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
Peers
100
S&P
68
2.48CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-49.7%WEAK▾
ROA?
S&P
3
-36.4%WEAK▾
Cash Flow & Enterprise
FCF?$-66346000
Enterprise Value?$96.6M
Fundamentals ratios updated end of day